Multiple proliferating tumor and endothelial cell targets

The term Multiple proliferating tumor and endothelial cell targets does not refer to a single, specific molecular entity, receptor, or enzyme. Instead, it is a descriptive phrase used to characterize the broad pharmacological profile of certain multi-targeted therapeutic agents, particularly multi-kinase inhibitors and anti-angiogenic drugs. These agents are designed to simultaneously inhibit various signaling pathways in both malignant cells (to stop tumor proliferation) and vascular endothelial cells (to inhibit angiogenesis). Common specific targets within this broad category include Vascular Endothelial Growth Factor Receptors (VEGFR), Platelet-Derived Growth Factor Receptors (PDGFR), and Fibroblast Growth Factor Receptors (FGFR). Because this entry represents a collection of distinct targets rather than a unique biological molecule, it is classified as an incorrect or non-specific target designation for structured pharmacological data.

Not applicable